Vers la page d'accueil
4.6/5
TrustPilot

Les meilleurs doctors à Solingen pour votre Immunothérapie avec Keytruda (Pembolizumab) - TOP 3 des médecins

Comparez les meilleurs médecins Immunothérapie avec Keytruda (Pembolizumab) et les prix en Allemagne. Trouvez votre meilleure correspondance ici.

Allemagne
Solingen

Obtenez des devis de 3 meilleurs spécialistes Immunothérapie avec Keytruda (Pembolizumab) en Allemagne

Nous sélectionnons à la main les meilleurs médecins selon vos besoins et votre budget.

Examiné médicalement par Fahad Mawlood

Éditeur Médical et Scientifique des Données

Meilleurs médecins

3

Allemagne

Avis

14000+

De vrais patients

Choisissez le pays avec les meilleurs prix pour les services médicaux

Comparez les prix de Immunothérapie avec Keytruda (Pembolizumab) dans les principaux pays

Touchez un pays pour voir les meilleurs médecins et prix

Turkey
Ukraine
South Korea
Mexico
Czech Republic
Canada
$3,300 - $10,000
$4,500 - $8,000
$5,200 - $8,500
$7,000 - $11,000
$7,500 - $10,500
$7,800 - $11,200
$0
$2,000
$4,000
$6,000
$8,000
$10,000
$12,000

Ce que paient réellement les patients Bookimed pour Immunothérapie avec Keytruda (Pembolizumab) en Allemagne

Gamme la plus populaire

$800

$1K

$1.2K

$1.6K

$2K

$1,100 – $1,500

La plupart des patients paient dans cette fourchette

Le coût exact dépend du médecin choisi, de la technique, des zones traitées et de vos besoins individuels.

Obtenez un devis précis pour votre cas.

Obtenez gratuitement des plans de traitement personnalisés et choisissez la meilleure option. Sans engagement · Aucun paiement pour nos services

Montrer d'abord :

Ralf Buhl

  • 4 Bien • 8 avis
  • 28 années d'expérience
  • + de 4000 traitements effectués
  • Lieu : Allemagne, Solingen
  • Clinique :
    4.7
    Medical Center in Solingen

  • Le Dr Buhl est spécialisé dans le traitement des métastases cérébrales et des anomalies vasculaires, alliant expertise clinique et recherche novatrice.

    • Auteur de 47 articles scientifiques sur la neuropathologie
    • Fondateur d'un fonds dédié à la recherche sur les tumeurs cérébrales
    • Effectue des interventions de neurochirurgie mini-invasive et endoscopique
    • Expert reconnu en neuro-oncologie et en pathologies vasculaires
  • Lire la suite
Visite du médecin
Prix sur demande

Manuela Seifert

  • Nouveau
  • 26 années d'expérience
  • accréditations:
  • Lieu : Allemagne, Solingen
  • Clinique :
    4.7
    Medical Center in Solingen

  • Le Dr Seifert dirige le Centre du cancer du sein de la Clinique Solingen, spécialisé dans les chirurgies conservatrices du sein et la reconstruction esthétique.

    • Plus de 20 ans d'expérience en gynécologie et dans le traitement du cancer du sein
    • Expert des techniques de conservation du sein et de la reconstruction plastique
    • Chef du Centre du cancer du sein de la Clinique Solingen
    • Fournit des soins complets, y compris un soutien psychologique
  • Lire la suite
Visite du médecin
Prix sur demande

Phd Viola Fox

  • Nouveau
  • 14 années d'expérience
  • Lieu : Allemagne, Solingen
  • Clinique :
    4.7
    Medical Center in Solingen

  • Spécialisé en immunothérapie pour les maladies tumorales, avec une expertise en Keytruda (Pembrolizumab). Reconnu pour ses recherches en biologie moléculaire dans le traitement du cancer.

    • Médecin-chef au centre de cancérologie interdisciplinaire certifié BKZ Solingen
    • Membre actif de l'American Association for Cancer Research
    • Spécialisé en chimiothérapie, immunothérapie et thérapies ciblées
    • Spécialiste qualifié en génétique
    • Travaille en étroite collaboration avec des hématologues de premier plan
  • Lire la suite
Visite du médecin
Prix sur demande

Choisir une clinique à l'étranger peut être stressant. Chez Bookimed, avec plus de 800 000 patients aidés, nous comprenons vos préoccupations. Nous savons comment trouver des médecins de confiance, les meilleures options qualité-prix, et des solutions pour les cas les plus complexes. Nous sommes là pour vous guider à chaque étape.

Yan Matsiivskiy

Responsable de l'équipe de coordination médicale

4300++ parcours patients accompagnés

3 années chez Bookimed

1022 patients du Germany ont trouvé leur médecin grâce à nous ce mois-ci

Comment obtenir la meilleure correspondance avec un médecin

1

Quiz de 2 minutes

Indiquez-nous votre objectif, budget, délai

2

Appariement humain + IA

Notre algorithme trouve des correspondances, le coordinateur vérifie l'adéquation

3

Vos options prêtes

Comparez les prix, forfaits, dates. Discutez avec votre coordinateur

Trop de choix ?

Votre personnel Le coordinateur Bookimed vous aide à trouver le chirurgien idéal adapté à vos besoins

  • Vous accompagne à chaque étape, 24h/24 et 7j/7
  • Vous aide à trouver le bon médecin et gère toute la communication avec les cliniques
  • Coordonne vos déplacements, hébergement et transferts

Accompagnement de votre traitement

Coordinateurs médicaux personnels formés

Peguy Beaugris
Tetyana Hyrych
Zekra Eldeeb
Victoria Olayinka
Iryna Sydorchuk
Tetiana Ihnatiuk

Choisir le bon médecin et la bonne clinique : conseils d'initiés

Lors du choix d’un médecin ou d’une clinique, gardez ces points essentiels à l’esprit :
Vérifiez les qualifications
Vérifiez les certifications d’organismes tels que l’ISAPS, la JCI, etc.
Examinez les taux de réussite
Choisissez des médecins ayant une solide expérience dans votre traitement spécifique.
Lisez les avis des patients
Consultez les avis patients réels sur Bookimed pour découvrir leur expérience.
Assurer la communication efficace
Choisissez des cliniques offrant un support linguistique pour un traitement fluide.
Demander les services
Vérifiez si le prix comprend des services tels que l’hébergement, les transferts locaux et le suivi afin d’éviter les coûts cachés.

Bookimed Insights : Meilleurs spécialistes d'immunothérapie avec Keytruda (Pembolizumab) en Allemagne (2026)

Bookimed a coordonné 36 demandes pour Immunothérapie avec Keytruda (Pembolizumab) en Allemagne, en collaboration avec 3 spécialistes. Les médecins de ce tableau se distinguent régulièrement par leurs qualifications et leur expertise à répondre aux besoins spécifiques des patients. Toutes les informations proviennent de cas réels de patients et d'offres de traitement créées par nos cliniques partenaires.
ClassementMédecinexpérienceBon choix pourCe qui les distingueClinique et emplacementConsultation
#1
Ralf Buhl
28 années d'expérienceMétastases cérébralesSe spécialise dans le traitement des métastases cérébrales grâce à des techniques chirurgicales avancées. Fondateur(trice) d'un fonds de recherche sur les tumeurs cérébrales. A publié de nombreux travaux sur des sujets de neurochirurgie.
Medical Center in Solingen
Allemagne
de $250
#2
Manuela Seifert
26 années d'expérienceChirurgies de conservation mammaireSpécialisé dans les techniques de conservation mammaire et la reconstruction esthétique. Chef du Centre du cancer du sein de la Clinique de Solingen, avec plus de 20 ans d'expérience.
Medical Center in Solingen
Allemagne
de $300
#3
Phd Viola Fox
14 années d'expérienceImmunothérapie avec KeytrudaExpert du traitement par Keytruda (Pembrolizumab) et de la recherche en biologie moléculaire. Médecin-chef au centre de cancérologie certifié du BKZ Solingen.
Medical Center in Solingen
Allemagne
Prix sur demande

FAQ

Ces FAQ sont basées sur les questions de patients réels cherchant des soins médicaux avec Bookimed. Les réponses sont fournies par des experts médicaux et des représentants de cliniques réputées.

Do I need special vaccinations or travel preparations before coming to Germany for Keytruda treatment?

Traveling to Germany for Keytruda requires specific medical preparations rather than mandatory entry vaccinations. You must avoid live vaccines like MMR or yellow fever during treatment. Essential steps include obtaining a medical invitation for a Schengen visa and preparing DICOM-format imaging for German oncologists.

  • Vaccine restrictions: Avoid live vaccines during immunotherapy and for 6 months after the final infusion.
  • Medical documentation: Bring pathology reports and recent CT or MRI scans on a USB drive.
  • Visa requirements: Non-EU citizens often need a Type C or D visa and clinic invitation.
  • Flight clearance: Secure a Fit to Fly certificate and wait 24–48 hours post-infusion before traveling.

Bookimed Expert Insight: While many focus on clinical entry, the logistical timing in Germany is the real differentiator. High-volume centers like Asklepios Hospital Barmbek, which serves 80,000 patients annually, suggest coordinating travel with 3 or 6-week infusion cycles. Choosing a clinic with international department support can expedite the official invitation letters required for German medical visas.

How safe is Keytruda (Pembrolizumab) immunotherapy in Germany, and which oncology centers are the most experienced?

Keytruda immunotherapy in Germany is highly safe due to strict European Medicines Agency (EMA) standards and specialized oncology centers. While 95.5% of patients experience side effects, most are manageable fatigue or rashes. Success relies on active monitoring for rare immune-mediated reactions in certified German Cancer Society facilities.

  • Safety standards: Oncology centers follow rigorous EMA protocols and German Cancer Society certification requirements.
  • Monitoring protocols: Clinics use molecular diagnostics to track immune-mediated reactions like pneumonitis or colitis.
  • Expert centers: Top facilities like Asklepios Barmbek and Medical Center Solingen serve 60,000+ patients annually.
  • Provider experience: Leading specialists like Dr. Viola Fox have over 15 years in drug-based tumor therapy.

Bookimed Expert Insight: Data shows that clinic choice matters less than the specific center's case volume for immune-related adverse events (irAEs). While large networks like Asklepios treat over 100,000 patients yearly, smaller oncology-specific centers like Bremen-Ost treat 500+ lung cancer cases annually. High-volume centers often have more robust internal protocols for managing complex thyroid or lung flare-ups linked to Pembrolizumab.

Patient Consensus: Patients emphasize that fatigue and joint pain are common realities often underplayed in brochures. Many advise discussing your baseline autoimmune status and specific immune monitoring frequency with your oncologist before starting treatment.

What clinical results can I realistically expect from pembrolizumab immunotherapy in Germany, and how is response monitored?

Clinical results for pembrolizumab in Germany include objective response rates of 48.5% for high PD-L1 lung cancer and 30.5-month median survival for melanoma. High-volume German oncology centers monitor progress via RECIST 1.1 CT scans every 9–12 weeks to differentiate true responses from pseudoprogression.

  • Survival outcomes: Advanced melanoma patients show a 55.4% 2-year survival probability in German clinical reports.
  • Expert evaluation: The Federal Joint Committee (G-BA) assigns added-benefit ratings to prioritize effective cancer subtypes.
  • Advanced imaging: PET/CT scans frequently assess metabolic tumor activity, especially before surgical interventions in neoadjuvant cases.
  • Safety tracking: Standard protocols require frequent blood panels to monitor liver, thyroid, and kidney health markers.

Bookimed Expert Insight: Clinical success in Germany often stems from strict adherence to German Cancer Society (DKG) protocols. Laboratories in centers like Medical Center Solingen perform high-precision PD-L1 testing before treatment. This ensures Keytruda is only used when success likelihood is highest, preventing unnecessary costs and side effects.

Patient Consensus: Patients value the use of digital health platforms to report symptoms instantly between clinical visits. This real-time feedback provides emotional security and ensures that immune-related side effects are addressed before they become serious.

Who is eligible for Keytruda therapy, and what pre-therapy testing is mandatory in Germany?

Eligibility for Keytruda in Germany depends on advanced or metastatic cancer stages and specific biomarker verification. Candidates typically include those with melanoma, non-small cell lung cancer, or classical Hodgkin lymphoma. German oncologists require validated PD-L1 expression levels or MSI/MMR status before approving this immunotherapy.

  • Biomarker testing: Mandatory PD-L1 IHC 22C3 assays or MSI-H status confirm treatment response probability.
  • Organ assessment: Doctors evaluate liver enzymes, kidney function, and thyroid health to manage risks.
  • Molecular profiling: Facilities like Nordwest Clinic use FoundationOne CDx panels for comprehensive genetic mapping.
  • Specialist approval: Multi-disciplinary teams at centers like Asklepios Hospital Barmbek must certify treatment.

Bookimed Expert Insight: German clinics often prioritize combination therapies over monotherapy for better outcomes. Data shows centers like Medical Center in Solingen use advanced molecular diagnostics to fast-track eligibility. Patients should account for a 4-week window for FoundationOne CDx results to avoid start-date delays.

Patient Consensus: Patients emphasize the need for early second-opinion pathology if initial biomarker results are borderline. Many suggest using official coverage tools before biopsy to ensure the costly diagnostic panels are approved.

Are there serious side-effects, and how are they prevented and managed?

Keytruda immunotherapy in Germany may cause immune-related adverse events affecting the lungs, liver, or endocrine system. German oncology centers prevent and manage these through rigorous molecular diagnostics and systemic monitoring to detect inflammatory responses before they escalate into serious organ damage.

  • Proactive monitoring: Surgeons use routine blood panels to check liver and kidney function markers.
  • Infusion protocols: Specialized clinics in Hamburg and Frankfurt deliver systemic pembrolizumab via outpatient infusions.
  • Early intervention: Low-dose corticosteroids effectively manage most inflammatory reactions when caught in early stages.
  • Specialized care: German Cancer Society certified centers follow strict protocols for immune-related adverse events.

Bookimed Expert Insight: German oncology centers like the Medical Center in Solingen emphasize molecular diagnostics before starting Keytruda. This approach allows doctors to predict how your immune system might react. With over 15,000 requests served in Germany, data shows that clinics with integrated research institutes, such as Nordwest, often have faster access to secondary treatments if traditional side-effect management fails.

Patient Consensus: Patients emphasize the importance of tracking even minor symptoms like skin rashes or fatigue early. Many recommend connecting with specialized oncology communities to understand the practical reality of managing immune-related inflammatory responses during long-term treatment.

How long does the treatment course take, and what is the follow-up schedule?

Immunotherapy with Keytruda in Germany typically lasts up to 2 years, involving approximately 35 cycles. Treatment follows a standard 3-weekly or an extended 6-weekly intravenous infusion schedule. Follow-up diagnostic imaging occurs every 2–3 months during active therapy to monitor tumor response and safety.

  • Treatment cycle: Administered as intravenous infusions every 3 or 6 weeks.
  • Standard duration: Most protocols suggest 24 months for maximum therapeutic benefit.
  • Monitoring schedule: CT or PET scans are performed every 8–12 weeks.
  • Post-treatment surveillance: Lifelong follow-up intervals eventually widen to every 6–12 months.

Bookimed Expert Insight: German oncology centers like Asklepios Hospital Barmbek and Medical Center Solingen increasingly utilize the 6-weekly dosing schedule. This protocol maintains efficacy while reducing hospital visits by 50% compared to 3-weekly cycles. This shift significantly improves quality of life for international patients traveling to Germany for specialized care.

Patient Consensus: Patients emphasize the importance of tracking scan dates and reporting skin or thyroid changes immediately. Many suggest discussing a personalized cycle count early, as deep remission may allow for a shortened 6-12 month course.

Can I continue immunotherapy at home after starting in Germany, and what documents will I need for my local oncologist?

Patients can continue immunotherapy at home following treatment in Germany if their local oncologist coordinates the transfer. Success depends on local drug approval and insurance coverage. German specialists typically provide comprehensive discharge summaries to ensure seamless medical continuity for follow-up care.

  • Medical reports: A German oncology report detailing diagnosis, TNM staging, and treatment history.
  • Treatment protocol: Specific Keytruda dosages, infusion schedules, and documented response to the drug.
  • Imaging data: Historical CT, MRI, or PET scans provided in DICOM digital format.
  • Pathology records: Original histology reports and paraffin blocks for local diagnostic second reviews.

Bookimed Expert Insight: German clinics like Asklepios Hospital Barmbek utilize digital portals to simplify medical handovers. Data shows these digital records are accepted by local oncologists 80% of the time. Patients should initiate communication between their German and local teams mid-treatment to prevent infusion lapses during the transition.

Patient Consensus: Most patients find the transition smoother when using digital patient portals for record sharing. It is vital to confirm local insurance coverage for Keytruda before the final German treatment session.

Will I need to stay in Germany beyond the infusion day, and what support services are available for international patients?

Most patients spend 1 to 3 days in Germany per Keytruda infusion cycle for monitoring and logistics. While the intravenous infusion takes 30-60 minutes as an outpatient procedure, clinics typically require pre-infusion bloodwork and 1-2 hours of post-dose observation for initial treatments.

  • Hospital stay: None required for routine cycles; patients are usually discharged the same day.
  • Buffer time: Budget 2 to 3 days for scans, bloodwork, and recovery travel buffers.
  • International support: Specialized offices provide medical visa assistance, airport transfers, and interpreter services.
  • Accommodation: Clinics often partner with nearby hotels offering rates around €100 per night.

Bookimed Expert Insight: While infusion is quick, Germany’s top oncology centers like Asklepios Hospital Barmbek and Nordwest Clinic often schedule diagnostics 24 hours prior. This staggered approach ensures your blood levels safely support immunotherapy. For international travelers, focusing on Hamburg or Frankfurt clinics often provides better access to dedicated English-speaking international offices and established hotel partnerships.

Patient Consensus: Expect a 1-2 hour wait after your first dose to monitor for reactions. Most patients recommend staying one extra night just in case and booking flexible flights to handle potential schedule shifts.